Israel Englander Pacific Biosciences Of California, Inc. Call Options Transaction History

Millennium Management LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$5.97 - $10.36 $20,895 - $36,260	3,500 Added 3.5%	103,500 $1.02 Million
Q2 2023 Aug 14, 2023	SELL	$9.97 - $14.05 $1.01 Million - $1.42 Million	-101,300 Reduced 50.32%	100,000 $1.33 Million
Q1 2023 May 15, 2023	BUY	$7.94 - $12.02 $804,322 - $1.22 Million	101,300 Added 101.3%	201,300 $2.33 Million
Q4 2022 Feb 14, 2023	SELL	$5.67 - $11.2 $2.27 Million - $4.49 Million	-401,000 Reduced 80.04%	100,000 $818,000
Q3 2022 Nov 14, 2022	BUY	$3.93 - $8.57 $1.18 Million - $2.58 Million	301,000 Added 150.5%	501,000 $2.91 Million

253

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $387M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.